abstract |
The present invention belongs to the field of pharmaceutical technology and relates to macrocyclic tyrosine kinase inhibitors and their uses. Specifically, the present invention relates to a compound of the general formula (I) or a pharmaceutically acceptable salt, ester or stereoisomer thereof, a method for preparing the compound, a pharmaceutical preparation or composition containing the same, and a pharmaceutical use thereof. .. |